Literature DB >> 25320002

The main cost drivers in dementia: a systematic review.

Sandra Schaller1, Josephine Mauskopf, Christine Kriza, Philip Wahlster, Peter L Kolominsky-Rabas.   

Abstract

OBJECTIVES: Because of the increasing prevalence of dementia worldwide, combined with limited healthcare expenditures, a better understanding of the main cost drivers of dementia in different care settings is needed.
METHODS: A systematic review of cost-of-illness (COI) studies in dementia was conducted from 2003 to 2012, searching the following databases: PubMed (Medline), Cochrane Library, ScienceDirect (Embase) and National Health Service Economic Evaluations Database. Costs (per patient) by care setting were analyzed for total, direct, indirect and informal costs and related to the following: (1) cost perspective and (2) disease severity.
RESULTS: In total, 27 studies from 14 different healthcare systems were evaluated. In the included studies, total annual costs for dementia of up to $70,911 per patient (mixed setting) were estimated (average estimate of total costs = $30,554). The shares of cost categories in the total costs for dementia indicate significant differences for different care settings. Overall main cost drivers of dementia are informal costs due to home based long term care and nursing home expenditures rather than direct medical costs (inpatient and outpatient services, medication).
CONCLUSIONS: The results of this review highlight the significant economic burden of dementia for patients, families and healthcare systems and thus are important for future health policy planning. The significant variation of cost estimates for different care settings underlines the need to understand and address the financial burden of dementia from both perspectives. For health policy planning in dementia, future COI studies should follow a quality standard protocol with clearly defined cost components and separate estimates by care setting and disease severity.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Alzheimer's disease; care setting; cost of illness; dementia; economics; health policy

Mesh:

Year:  2014        PMID: 25320002     DOI: 10.1002/gps.4198

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  52 in total

1.  Association of Sensory and Cognitive Impairment With Healthcare Utilization and Cost in Older Adults.

Authors:  William James Deardorff; Phillip L Liu; Richard Sloane; Courtney Van Houtven; Carl F Pieper; Susan Nicole Hastings; Harvey J Cohen; Heather E Whitson
Journal:  J Am Geriatr Soc       Date:  2019-03-29       Impact factor: 5.562

Review 2.  Home is where the future is: The BrightFocus Foundation consensus panel on dementia care.

Authors:  Quincy M Samus; Betty Smith Black; Diane Bovenkamp; Michael Buckley; Christopher Callahan; Karen Davis; Laura N Gitlin; Nancy Hodgson; Deirdre Johnston; Helen C Kales; Michele Karel; John Jay Kenney; Shari M Ling; Maï Panchal; Melissa Reuland; Amber Willink; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2017-11-21       Impact factor: 21.566

3.  Long-Term Intake of Dietary Carotenoids Is Positively Associated with Late-Life Subjective Cognitive Function in a Prospective Study in US Women.

Authors:  Changzheng Yuan; Elinor Fondell; Alberto Ascherio; Olivia I Okereke; Francine Grodstein; Albert Hofman; Walter C Willett
Journal:  J Nutr       Date:  2020-07-01       Impact factor: 4.798

4.  Classification tree model of the personal economic burden of dementia care by related factors of both people with dementia and caregivers in Japan: a cross-sectional online survey.

Authors:  Takayo Nakabe; Noriko Sasaki; Hironori Uematsu; Susumu Kunisawa; Anders Wimo; Yuichi Imanaka
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

Review 5.  The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review.

Authors:  Juan Oliva-Moreno; Marta Trapero-Bertran; Luz Maria Peña-Longobardo; Raúl Del Pozo-Rubio
Journal:  Pharmacoeconomics       Date:  2017-03       Impact factor: 4.981

Review 6.  Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms.

Authors:  Laure Rouch; Philippe Cestac; Olivier Hanon; Charlène Cool; Catherine Helmer; Béatrice Bouhanick; Bernard Chamontin; Jean-Franҫois Dartigues; Bruno Vellas; Sandrine Andrieu
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

7.  Self-Reported Sleep Apnea and Dementia Risk: Findings from the Prevention of Alzheimer's Disease with Vitamin E and Selenium Trial.

Authors:  Xiuhua Ding; Richard J Kryscio; Joshua Turner; Gregory A Jicha; Gregory Cooper; Allison Caban-Holt; Frederick A Schmitt; Erin L Abner
Journal:  J Am Geriatr Soc       Date:  2016-11-01       Impact factor: 5.562

8.  Direct medical expenditures associated with Alzheimer's and related dementias (ADRD) in a nationally representative sample of older adults - an excess cost approach.

Authors:  Arijita Deb; Usha Sambamoorthi; James Douglas Thornton; Bernard Schreurs; Kim Innes
Journal:  Aging Ment Health       Date:  2017-02-08       Impact factor: 3.658

9.  A Scoping Review of Dementia Symptom Management in Persons with Dementia Living in Home-based Settings.

Authors:  Catherine E Schneider; Alycia A Bristol; Abraham A Brody
Journal:  Curr Geriatr Rep       Date:  2019-11-18

10.  Mental Component Score (MCS) from Health-Related Quality of Life Predicts Incidence of Dementia in U.S. Males.

Authors:  X Ding; E L Abner; F A Schmitt; J Crowley; P Goodman; R J Kryscio
Journal:  J Prev Alzheimers Dis       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.